Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice

被引:0
|
作者
Melisa J. Hamilton
Judit P. Banáth
Vivian Lam
Nancy E. LePard
Gerald Krystal
Kevin L. Bennewith
机构
[1] British Columbia Cancer Agency Research Centre,Terry Fox Laboratory
[2] British Columbia Cancer Agency Research Centre,Department of Integrative Oncology
[3] British Columbia Cancer Agency Research Centre,Department of Integrative Oncology
来源
关键词
Myeloid-derived suppressor cells (MDSCs); Immune suppression; 4T1 tumor cells; Serum; Albumin;
D O I
暂无
中图分类号
学科分类号
摘要
As more groups investigate the role of myeloid-derived suppressor cells (MDSCs) in promoting the growth of primary tumors and distant tumor metastases, it is imperative to ensure the accurate detection and quantification of MDSC immunosuppression ex vivo. MDSCs are defined by their ability to suppress immune responses. Although different in vitro culture conditions have been used to study MDSCs, the effect of different culture conditions on MDSC immunosuppression is unknown. We therefore isolated MDSCs from the lungs and spleens of 4T1 murine mammary tumor-bearing mice and assayed MDSC-mediated suppression of T cell responses under different culture conditions. We found that 4T1-induced MDSCs effectively suppressed T cell proliferation under serum-free conditions, but not when fetal calf serum (FCS) was present. FCS neither altered the immunosuppressive activities of other myeloid cell types (i.e., peritoneal or tumor-associated macrophages) nor modified the susceptibility of T cells to myeloid cell-mediated suppression, but instead acted directly on 4T1-induced MDSCs to significantly reduce their immunosuppressive function. Importantly, we found that bovine serum albumin was a major contributor to the antagonistic effects of FCS on 4T1-induced MDSC immunosuppression by inhibiting reactive oxygen species production from MDSCs. This work reveals that in vitro culture conditions influence the immunosuppressive properties of MDSCs and highlights the importance of testing different culture conditions on MDSC phenotype to ensure that MDSC immunosuppression is not being masked. These data have important implications for the accurate detection and identification of MDSCs, as well as for determining the influence of MDSC-mediated immunosuppression on primary and metastatic tumor growth.
引用
下载
收藏
页码:643 / 654
页数:11
相关论文
共 50 条
  • [21] Phototheranostics of Splenic Myeloid-Derived Suppressor Cells and Its Impact on Spleen Metabolism in Tumor-Bearing Mice
    Barnett, James D.
    Jin, Jiefu
    Penet, Marie-France
    Kobayashi, Hisataka
    Bhujwalla, Zaver M.
    CANCERS, 2022, 14 (15)
  • [22] A single cell sequencing approach to understand the nature of myeloid-derived suppressor cells in tumor-bearing mice
    Abdulla, Osama Azeldeen
    Wilson, Kiesha
    Nagarkatti, Prakash
    Nagarkatti, Mitzi
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [23] Lipidomics data showing the effect of lipofermata on myeloid-derived suppressor cells in the spleens of tumor-bearing mice
    Adeshakin, Adeleye Oluwatosin
    Adeshakin, Funmilayo O.
    Liu, Wan
    Li, Hua
    Yan, Dehong
    Wan, Xiaochun
    DATA IN BRIEF, 2021, 35
  • [24] Astaxanthin Treatment Induces Maturation and Functional Change of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
    Jeong, Seong Mun
    Kim, Yeon-Jeong
    ANTIOXIDANTS, 2020, 9 (04)
  • [25] Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice
    Veglia, Filippo
    Hashimoto, Ayumi
    Dweep, Harsh
    Sanseviero, Emilio
    De Leo, Alessandra
    Tcyganov, Evgenii
    Kossenkov, Andrew
    Mulligan, Charles
    Nam, Brian
    Masters, Gregory
    Patel, Jaymala
    Bhargava, Vipul
    Wilkinson, Patrick
    Smirnov, Denis
    Sepulveda, Manuel A.
    Singhal, Sunil
    Eruslanov, Evgeniy B.
    Cristescu, Razvan
    Loboda, Andrey
    Nefedova, Yulia
    Gabrilovich, Dmitry I.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (04):
  • [26] Different characteristics of Myeloid-derived suppressor cells from septic and tumor bearing mice
    Shu, Qiang
    Qin, Chaojin
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [27] Regulation of myeloid-derived suppressor cells (MDSCs) in mammary tumor bearing mice
    Reed, Elizabeth
    Abe, Fuminori
    Hamdy, Ibrahim
    Westphal, Sherry
    Dafferner, Alicia
    Hoke, Traci
    Samson, Holly
    Talmadge, James
    CANCER RESEARCH, 2009, 69
  • [28] Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice
    Ma, Chi
    Kapanadze, Tamar
    Gamrekelashvili, Jaba
    Manns, Michael P.
    Korangy, Firouzeh
    Greten, Tim F.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2012, 92 (06) : 1199 - 1206
  • [29] Sustained IFNalpha treatment inhibits metastasis in 4T1 mammary carcinoma and correlates with decreasing myeloid-derived suppressor cells
    Kochel, Christina
    Pande, Kalyan
    Ueda, Roanna
    Gorman, Dan
    Laface, Drake
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [30] Lipid metabolic pathways confer immunosuppressive function of myeloid-derived suppressor cells in tumor
    Yan, D.
    Adeleye, O. A.
    Zhang, M.
    Xu, M.
    Chen, Y. H.
    Wan, X.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1296 - 1297